The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

The Russian invasion of Ukraine:

Implication for hematologists and oncologists

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

No modern war has been fought on the territory of a country with nuclear power facilities.

Today, the Russian troops have entered the territory of Ukraine.  This incursion is causing a substantial, immediate loss of lives on both sides of the conflict, but few people have considered other potential consequences of interest and concern to readers of The Cancer Letter. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Robert Peter Gale, MD, PhD, DSC(hc), FACP, FRCP, FRCPI(hon), FRSM, LHD, DPS
Visiting professor of haematology, Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London
Table of Contents

YOU MAY BE INTERESTED IN

U.S., Sweden sign cancer research and innovation pact as part of preparedness plan for potential Russian aggression

U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.
By Matthew Bin Han Ong
Guest Editorial

How insights we gained at AACR will help modernize cancer care in Ukraine

Ukraine is experiencing a full-scale war that has been going on for more than a year. The resilience of the Ukrainian people, the balanced policy of the government led by the president of Ukraine, and the strong support of the world community inspire hope for victory and the country’s speedy recovery.
By Serhii Kozhukhov, Olena Yefimenko, Stepan Krulko, Liudmyla Ostrovska, Emily Hubbard and Rostyslav Semikov
Byline
Robert Peter Gale, MD, PhD, DSC(hc), FACP, FRCP, FRCPI(hon), FRSM, LHD, DPS
Visiting professor of haematology, Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account